loader image
Saturday, October 12, 2024
79.2 F
McAllen
We Welcome your Press Release
- Advertisement -

Director and research team for UTRGV South Texas Diabetes and Obesity Institute to be announced Monday

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Two news conferences will be held Monday morning to announce that Dr. Sarah Williams-Blangero, a nationally renowned genetics and infectious disease expert, will be the inaugural director of the UTRGV South Texas Diabetes and Obesity Institute.

In addition, Dr. Williams-Blangero, former chair of the department of genetics at the Texas Biomedical Research Institute in San Antonio, is bringing a 22-person team of expert researchers and support staff with her to UTRGV.

The first news conference will take place at 9 a.m. in Salon Cassia at UT Brownsville’s Main (formerly the Education and Business Complex) and will be webcast live at media.utb.edu/live.aspx. The second news conference will begin at 11:15 a.m. in UT Pan American’s University Ballroom and will be webcast live at UTPA.edu/LIVE.

- Advertisement -

Both events will include remarks from Dr. Williams-Blangero; Chancellor Francisco G. Cigarroa, M.D.; Guy Bailey, founding president of UT Rio Grande Valley; and Francisco Fernandez, M.D., founding dean of the UTRGV School of Medicine.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

From Pigs to Payouts: Weighing Solutions for the U.S. Kidney Shortage

The U.S. kidney shortage has reached a critical point, with nearly 90,000 people waiting for transplants and only around 27,000 performed this year, according to a report by Caroline Catherman in Healthcare Brew (September 2024). The United Network for Organ Sharing (UNOS) warns that one in 20 people on the waitlist dies each year. Experts grapple with this crisis, seeking solutions from financial incentives to medical innovation.

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.

DHR Health Brownsville Leads the Way in Minimally Invasive Robotic Surgery

DHR Health stands at the forefront of minimally invasive robotic surgery in South Texas, exemplified by its Institute of Robotic Surgery, which successfully completes over 1,000 robotic cases annually. With the recent inauguration of DHR Health Brownsville, this advanced expertise in Minimally Invasive Surgical procedures is extending its reach to the lower Rio Grande Valley. In a groundbreaking milestone last month, Dr. Rene Luna conducted DHR Health Brownsville's inaugural Robotic Surgery.
- Advertisement -
×